Pros | - | Larger AUM within category. | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 1 Years | 4 Years | ||
Fund Size | 157 Cr | 8204 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹1000 | ||
Expense Ratio | 0.5% | 0.45% | ||
Exit Load | 0.25% | 0% | ||
Benchmark Index | Nifty MidSmall Healthcare Index (TRI) | Nifty200 Momentum 30 TR INR |
No of Holdings | 32 | 32 | ||
Top 5 Holdings | Fortis Healthcare Ltd (9.63%) Lupin Ltd (8.81%) Laurus Labs Ltd (6.23%) Alkem Laboratories Ltd (5.82%) Aurobindo Pharma Ltd (5.78%) | Bajaj Finance Ltd (5.65%) Bajaj Finserv Ltd (5.23%) Bharat Electronics Ltd (5.22%) InterGlobe Aviation Ltd (5.21%) SBI Life Insurance Co Ltd (5.07%) | ||
No of Sectors | 1 | 9 | ||
Top 3 Sectors | Health (100%) | Corporate (100%) Financial Services (50.03%) Industrial (14.97%) | ||
Equity % | 100.08% | 100% | ||
Debt % | - | - | ||
P/E | 38.2 | 38.6 | ||
P/B | 5.31 | 6.74 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.15% | 5.35% | ||
3-Month Return | -2.7% | 4.07% | ||
6-Month Return | 7.98% | 7.54% | ||
1-Year Return | 2.93% | -8.37% | ||
3-Year Return | - | 16.97% | ||
5-Year Return | - | - |
Sharpe | - | 0.6 | ||
Alpha | - | -0.17 | ||
Beta | - | 1 | ||
Standard Deviation | - | 17.77 | ||
Information Ratio | - | -1.06 |
Description | Tata Nifty MidSmall Healthcare Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | UTI Nifty200 Momentum 30 Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rakesh Prajapati,Nitin Sharma | Ayush Jain,Sharwan Kumar Goyal |